D-Limonene: A bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment

Jessica A. Miller, Patricia A. Thompson, Iman A Hakim, Hsiao-Hui Chow, Cynthia Thomson

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Although limited, observations from cell culture, animal, and epidemiological studies support the presence of anti-cancer properties in citrus peel and the primary bioactive food constituent, d-limonene. Early evidence from animal models suggests that when ingested, d-limonene exhibits a wide spectrum of biologic activity including chemotherapeutic and chemopreventive effects. In some of these early models, an analog of d-limonene, perillyl alcohol, demonstrated a more potent effect than d-limonene itself. Yet, when perillyl alcohol advanced to clinical trials, several trials were ended early due to dose-limiting toxicities. Alternatively, oral d-limonene administration in humans is well tolerated even at high doses supporting its investigation as a potential bioactive for cancer prevention. Though the exact mechanisms of action of d-limonene are unclear, immune modulation and anti-proliferative effects are commonly reported. Here, we review the pre-clinical evidence for d-limonene's anti-cancer mechanisms, bioavailability, and safety, as well as the evidence for anti-cancer effects in humans, focusing on studies relevant to its use in the prevention and treatment of breast cancer.

Original languageEnglish (US)
Pages (from-to)31-42
Number of pages12
JournalOncology Reviews
Volume5
Issue number1
DOIs
StatePublished - Mar 2011

Fingerprint

Citrus
Breast Neoplasms
perilla alcohol
Food
Neoplasms
limonene
Biological Availability
Epidemiologic Studies
Animal Models
Cell Culture Techniques
Clinical Trials
Safety

Keywords

  • Bioactive food component
  • Breast cancer
  • d-Limonene
  • Perillyl alcohol

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

D-Limonene : A bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment. / Miller, Jessica A.; Thompson, Patricia A.; Hakim, Iman A; Chow, Hsiao-Hui; Thomson, Cynthia.

In: Oncology Reviews, Vol. 5, No. 1, 03.2011, p. 31-42.

Research output: Contribution to journalArticle

@article{0c3e6168e81b402ca7959941f8012f1b,
title = "D-Limonene: A bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment",
abstract = "Although limited, observations from cell culture, animal, and epidemiological studies support the presence of anti-cancer properties in citrus peel and the primary bioactive food constituent, d-limonene. Early evidence from animal models suggests that when ingested, d-limonene exhibits a wide spectrum of biologic activity including chemotherapeutic and chemopreventive effects. In some of these early models, an analog of d-limonene, perillyl alcohol, demonstrated a more potent effect than d-limonene itself. Yet, when perillyl alcohol advanced to clinical trials, several trials were ended early due to dose-limiting toxicities. Alternatively, oral d-limonene administration in humans is well tolerated even at high doses supporting its investigation as a potential bioactive for cancer prevention. Though the exact mechanisms of action of d-limonene are unclear, immune modulation and anti-proliferative effects are commonly reported. Here, we review the pre-clinical evidence for d-limonene's anti-cancer mechanisms, bioavailability, and safety, as well as the evidence for anti-cancer effects in humans, focusing on studies relevant to its use in the prevention and treatment of breast cancer.",
keywords = "Bioactive food component, Breast cancer, d-Limonene, Perillyl alcohol",
author = "Miller, {Jessica A.} and Thompson, {Patricia A.} and Hakim, {Iman A} and Hsiao-Hui Chow and Cynthia Thomson",
year = "2011",
month = "3",
doi = "10.1007/s12156-010-0066-8",
language = "English (US)",
volume = "5",
pages = "31--42",
journal = "Oncology Reviews",
issn = "1970-5557",
publisher = "PagePress",
number = "1",

}

TY - JOUR

T1 - D-Limonene

T2 - A bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment

AU - Miller, Jessica A.

AU - Thompson, Patricia A.

AU - Hakim, Iman A

AU - Chow, Hsiao-Hui

AU - Thomson, Cynthia

PY - 2011/3

Y1 - 2011/3

N2 - Although limited, observations from cell culture, animal, and epidemiological studies support the presence of anti-cancer properties in citrus peel and the primary bioactive food constituent, d-limonene. Early evidence from animal models suggests that when ingested, d-limonene exhibits a wide spectrum of biologic activity including chemotherapeutic and chemopreventive effects. In some of these early models, an analog of d-limonene, perillyl alcohol, demonstrated a more potent effect than d-limonene itself. Yet, when perillyl alcohol advanced to clinical trials, several trials were ended early due to dose-limiting toxicities. Alternatively, oral d-limonene administration in humans is well tolerated even at high doses supporting its investigation as a potential bioactive for cancer prevention. Though the exact mechanisms of action of d-limonene are unclear, immune modulation and anti-proliferative effects are commonly reported. Here, we review the pre-clinical evidence for d-limonene's anti-cancer mechanisms, bioavailability, and safety, as well as the evidence for anti-cancer effects in humans, focusing on studies relevant to its use in the prevention and treatment of breast cancer.

AB - Although limited, observations from cell culture, animal, and epidemiological studies support the presence of anti-cancer properties in citrus peel and the primary bioactive food constituent, d-limonene. Early evidence from animal models suggests that when ingested, d-limonene exhibits a wide spectrum of biologic activity including chemotherapeutic and chemopreventive effects. In some of these early models, an analog of d-limonene, perillyl alcohol, demonstrated a more potent effect than d-limonene itself. Yet, when perillyl alcohol advanced to clinical trials, several trials were ended early due to dose-limiting toxicities. Alternatively, oral d-limonene administration in humans is well tolerated even at high doses supporting its investigation as a potential bioactive for cancer prevention. Though the exact mechanisms of action of d-limonene are unclear, immune modulation and anti-proliferative effects are commonly reported. Here, we review the pre-clinical evidence for d-limonene's anti-cancer mechanisms, bioavailability, and safety, as well as the evidence for anti-cancer effects in humans, focusing on studies relevant to its use in the prevention and treatment of breast cancer.

KW - Bioactive food component

KW - Breast cancer

KW - d-Limonene

KW - Perillyl alcohol

UR - http://www.scopus.com/inward/record.url?scp=79954575341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954575341&partnerID=8YFLogxK

U2 - 10.1007/s12156-010-0066-8

DO - 10.1007/s12156-010-0066-8

M3 - Article

AN - SCOPUS:79954575341

VL - 5

SP - 31

EP - 42

JO - Oncology Reviews

JF - Oncology Reviews

SN - 1970-5557

IS - 1

ER -